GENinCode (LON:GENI) Stock Price Down 11.6% – Should You Sell?

GENinCode Plc (LON:GENIGet Free Report) shares were down 11.6% on Thursday . The stock traded as low as GBX 1.10 and last traded at GBX 1.11. Approximately 6,105,473 shares changed hands during mid-day trading, a decline of 0% from the average daily volume of 6,128,636 shares. The stock had previously closed at GBX 1.25.

GENinCode Stock Up 1.7%

The company has a quick ratio of 15.89, a current ratio of 2.80 and a debt-to-equity ratio of 7.17. The company has a market capitalization of £8.48 million, a P/E ratio of -0.50 and a beta of 0.61. The firm has a 50-day moving average price of GBX 1.13 and a two-hundred day moving average price of GBX 1.55.

About GENinCode

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.

Further Reading

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.